INVO Fertility, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
INVO Fertility, Inc. (IVF) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $2.15 million for the 12-month period ending 2023-12-31, per its 10-K/A filed 2024-11-19.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2024-11-19
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-12-31 was $0.00.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2023-09-30 was $1.22M.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2021-12-31 was $601.39K.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2021-09-30 was $0.00.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $2.15M.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $1.58M.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- INVO Fertility, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2019 was $116.44K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-11-19 | $1.22M derived: sum of 2 quarters · filed 2024-11-19 | $2.15M 10-K/A · filed 2024-11-19 | |
| 2023-09-30 | $1.22M derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-11-19 | $2.15M 10-K/A · filed 2024-11-19 | ||
| 2023-06-30 | $922.52K 10-K/A · filed 2024-11-19 | |||
| 2021-12-31 | $601.39K derived: 10-K/A 12 month − 10-K/A 9 month · filed 2024-11-19 | $601.39K derived: sum of 2 quarters · filed 2024-11-19 | $1.58M 10-K/A · filed 2024-11-19 | |
| 2021-09-30 | $0.00 derived: 10-K/A 9 month − 10-K/A 6 month · filed 2024-11-19 | $978.42K 10-K/A · filed 2024-11-19 | ||
| 2021-06-30 | $978.42K 10-K/A · filed 2024-11-19 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $0.00 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | $0.00 10-Q · filed 2020-08-13 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $116.44K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $116.44K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $116.44K 10-Q · filed 2020-08-13 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |